ARN No Codificante Terapéutico, Microproteínas y Estrés Integrado en Cáncer
NONCOD
University Hospital of Lausanne
Lausana, SuizaPublications in collaboration with researchers from University Hospital of Lausanne (9)
2022
-
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
Gut, Vol. 71, Núm. 9, pp. 1856-1866
-
Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis
Hepatology, Vol. 75, Núm. 4, pp. 968-982
-
Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer
Gut, Vol. 71, Núm. 10, pp. 2069-2080
2020
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
-
Intratumoral heterogeneity and clonal evolution in liver cancer
Nature Communications, Vol. 11, Núm. 1
2019
-
A phenotypical map of disseminated hepatocellular carcinoma suggests clonal constraints in metastatic sites
Histopathology, Vol. 74, Núm. 5, pp. 718-730
2018
-
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
Oncogene, Vol. 37, Núm. 27, pp. 3740-3752
-
High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma
Scientific Reports, Vol. 8, Núm. 1
2016
-
Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease-hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective
Clinical Liver Disease, Vol. 8, Núm. 4, pp. 100-104